PROLONGED COMAS AND STRESS:
POSSIBLE DRUG THERAPY?
By Renato COCCHI, MD, neurologist and
medical psychologist
Key words: Coma, stress, GABA, glutamate,
EEG, drug therapy, carbamazepine, speculation.
I consider comas as an
extreme brain reaction to stress. Of course it would be hard to consider any
type of coma so. When we are faced to comas "sine materia", like
anoxic comas, this assertion seems easier to be accepted.
Some prolonged comas can
have unexpected awakenings after years, although the physicians ' contrary
opinion. This is a challenging medical and ethical problem with heavy
economical implications.
On the other hand an
Italian rehabilitative centre soon recently claimed to be able to successfully
treat such comas with stimulatory therapies, mainly with music.
We need to develop a
coherent frame of reference to understand those awakenings, eventually not so
rare.
As an example, in July 1999
we have read the news that another 20-year young man awoke from a coma that has
lasted two years. This coma followed a motorbike accident. In these two years,
during his stay in the hospital of Terracina (Italy) he had many surgical
operations and sensory stimulation therapies. Although the doctors told the
family of the futility of these treatments the parents never accepted it and 10
days before they had taken their son home. His awakening was first manifested
with a gesture and soon after by asking for food.
I do not think this to be a
miraculous event but rather a medical problem. So I should like to put forward
some ideas that I have developed over the years.
Perhaps we lack a coherent
frame of reference for understanding phenomena like these, which appear to us
so unexpected.
We have the misleading idea
that a negative outcome (the coma) can only derive from a whole negative
process (lack of brain "energy").
The opposite is also
possible at least in part. The coma could be the exit of an excess of
"energy," like type B GABAergic inhibition and glutamergic
overstimulation, both because of an extreme stress. Of course the starting
point is a negative process, the decrease of type A GABAergic inhibition
(Horger and Roth, 1995).
As for comas, their EEG
with very slow waves (delta waves) could confirm that GABA is involved, when we
make an analogy with what happens by using GABAergic drugs like valproate,
gabapentin or vigabatrin in normal or epileptic people.
As far as increased glutamergic
overstimulation, this usually results following sustained stress reactions
(Horger and Roth, 1995).
Any stimulation - sensorily
and/or emotionally targeted or even surgical stimulation (a side-effect of any
surgical aim) - can decrease the excess of glutamate by consumption.
The perceptive neuronal
pathways use mainly glutamate as their neurotransmitter (see Budai and Larson,
1998 for many references).
By this way the
"spontaneous" awakening from the coma could come out by a reverse
cascade of events, although not fully clarified mainly for the action of
glutamate on type A GABAergic receptors (Horger and Roth, 1995).
Consumption is a not yet
underlined mechanism of the human body biology but the need to do something at
weekends by several "neurotic" Ss (often the so-called
"job-addicts") can lead us to understand it. Their behaviour (they
cannot rest otherwise they became irritated or suffer from psychosomatic
symptoms like headaches), is a diffused behaviour of consumption. I wrote the
same for rocking in autistic or other PDD children or in depressed children
too, where it owns an evident calming action as the "artificial"
rocking of the cradle testifies for it (Cocchi, 1997).
On the other hand, as for
epilepsy we can act on EEG-waves by using correct drugs. The little known rule
of the thumb should be: When EEG detects slow waves we can try to balance them
by prescribing accelerating drugs like benzodiazepines or carbamazepines. When
EEG detects rapid waves we can try to decrease them by using slowing drugs like
valproate and so on. I have previously reported the use of accelerating drugs
in treating people with pseudodementia showing delta-theta waves and I
monitored their positive effects by QEEG (Cocchi, 1996).
As a concluding anecdote,
when I was working in the Pesaro psychiatric hospital, about in first
seventies, one day I was called suddenly because a young man had hang himself.
Immediately helped, he was into a serious coma. By intuition I decided to
inject 10mg diazepam i.v.. To everybody surprise he directly awoke from the
coma.
Now I know that in this way
I reopened type A GABAergic receptors with diazepam, so reducing synaptic GABA
overacting on type B GABAergic receptors. By backwards, glutamic acid
decarboxylase (GAD) could have restarted its action and so it reduced glutamate
by increasing its transformation into GABA.
By directly acting on these
three points - with diazepam for promoting type A GABAergic inhibition, with
carbamazepine as a brain Ca++ antagonist (Crowder and Bradford, 1987) for
decreasing type B GABAergic inhibition and with pyridoxine for improving GAD
activity with pyridoxal-phosphate, cofactor of all decarboxylases - could we
act on comas? Of course, to give diazepam to a comatose person should appear a
heretical suggestion but I tried to explain the rationale and QEEG can daily
monitor the progress (if any) of such a trial.
Prolonged comas are a
medical challenge, and these "spontaneous" awakenings shall force the
doctors to delay any final decision with increased hospital costs, for not to
say of related ethical problems.
You can ask me why I do not
put into action this suggestion by myself? I do not work in an intensive care
unit, and in Italy doctors do not like new procedures, if they do not have any
foreign corroboration.
See also: News10.htm
References.
Budai D, Larson AA. The involvement of metabotropic glutamate receptors in sensory transmission in dorsal horn of the rat spinal cord. Neuroscience 1998, 83: 571-580.
Cocchi R. Drug therapy of pseudodementia as modulation of stress reactions. It. J. Intellect. Impair. 1996, 9: 173-180.
Cocchi R. Rocking as consummatory behaviour against a glutammate excess? It. J. Intellect. Impair. 1997, 10: 7-12.
Crowder JM, Bradford HF. Common anticonvulsant inhibit Ca++ uptake and amino acid neurotransmitter release in vitro. Epilepsia 1987, 28: 378-382.
Horger BA, Roth RH. Stress and central amino acid system. In: Friedman MJ, Charney DS, Deutch AJ. (eds). Neurobiological and clinical consequences of stress: From normal adaptation to PTSD. Lippincott-Raven, Philadelphia, 1995: 61-81.
Presented at the 3rd World Congress on Stress, Dublin 24-27 September 2000
Author's address: dr Renato COCCHI, via
Rabbeno, 3
42100 Reggio Emilia (Italy)
renatococchi@libero.it
Speculation
Drug modulation of stress responses
Home Page